Skip to main content
International Wound Journal logoLink to International Wound Journal
. 2007 Sep 24;4(Suppl 3):9–17. doi: 10.1111/j.1742-481X.2007.00388.x

Wound bed preparation and oxygen balance – a new component?

R Gary Sibbald 1, Kevin Y Woo 2, Douglas Queen 3
PMCID: PMC7951220  PMID: 17894663

Abstract

Chronic wounds have traditionally been treated by conservative means. It was Winter’s moist wound healing research, in 1962, that stimulated a proliferation of a moist interactive dressing technologies. Even considering this advancement in thinking, chronic wounds continue to be a problem for many clinicians. An increasing delineation of the science of healing in the past 20 years has redefined the way in which we both evaluate and treat wounds. This scientific understanding has raised wound care from the clinical problem arena to that of clinical specialty, where many now cross refer patients to specialists in this field. Wound bed preparation (WBP) has played a significant role in this change in practice. The concept has changed an ‘art’ of switching at random from one dressing to another, into a clinical science. WBP has come to the forefront as a major educational aid to help others develop appropriate treatment of the underlying disease causing the wound and patient requirements. The concept of WBP evolved over the recent years, becoming more and more sophisticated with time. Recent adaptations have brought together many of the current components. This article proposes yet another element of WBP, that of ‘oxygen balance’.

Keywords: Debridement, Infection, Inflammation, Moisture balance, Oxygenation, Oxygen balance, Wound bed preparation, Wound edge

Background

Chronic wounds are often resistant to healing and do not follow the expected trajectory (30% smaller in 12 weeks) (1). Increasing scientific evidence suggests that many chronic wounds contain phenotypically altered cells with diminished molecular and cellular responses to promote healing (2). There may also be impaired cell migration and insufficient angiogenesis to support complete closure with an imbalance favoring tissue destruction modulated by matrix metalloproteases (3). The debilitating and chronicity of these wounds constitute a significant burden, especially in the older population (4). As our society continues to age, this demographic shift demands a different approach to delivering chronic wound care.

The optimal care of individuals with chronic wounds is complex and interpolated with local wound issues, patient‐centred concerns of individual patients, and problems with healthcare systems that may potentially thwart healing. As wound care knowledge has evolved since Winter (5) established the importance of moist healing in 1962, a plethora of modern dressings had emerged with varying abilities to interact with the wound environment (6). However, wound healing does not always follow delivery of appropriate local wound care, especially if the underlying cause and patient centred concerns are not taken into account (7).

To ensure a systematic approach to wound care, Sibbald et al. (8) proposed the wound bed preparation (WBP) paradigm that links treatment to the underlying cause and patient‐centred concerns with three key components of local wound care: debridement, control of infection (bioburden)/prolonged inflammation and moisture balance.

Treat the underlying cause

This is the first step in a professional approach to chronic wounds including examples such as, compression in venous disease and plantar pressure redistribution for diabetic neuropathic foot ulcers (where infection is kept under control and tissue perfusion is adequate for healing). For pressure ulcers, clinicians need to optimise pressure relief and they should also optimise nutritional status, prevent friction and shear, control excess moisture from incontinence of stool and urine, maximise mobility and promote frequent turning (Table 1) (8).

Table 1.

Important elements of treating the cause of various wound types (28)

Conditions Treatment
Venous disease High compression in the absence of significant arterial disease (ABI ≥ 0·8)
Diabetic foot ulcer Think VIPS: Vascular supply: adequate for healing; Infection: Bacterial balance; Pressure: plantar redistribution; Sharp surgical debridement
Pressure ulcers Pressure redistribution, nutrition, friction and shear, moisture control, increase mobility

Although complete healing may seem to be the logical goal for most patients, some wounds do not have the ability to heal because of one or more of the following: inadequate vasculature, a cause that is not treatable/correctable, coexisting medical conditions or prescribed drugs that impede the healing process (7). Health care professionals and patients must be cognisant of the fact that not all chronic wounds are healable or have the ability to heal (9). Healable wounds have several requirements starting with adequate tissue perfusion. In addition, patients with these wounds do not have any coexisting medical conditions (e.g. advanced cancer) or prescribed medication (e.g. immunosuppressive drugs) that would prevent normal healing. A maintenance wound is a wound with the ability to heal but either the patient does not consistently adhere to treatment or the health care system may restrict access to appropriate resources. A patient with a non healable wound has inadequate vasculature, a cause that is not treatable, coexisting medical conditions exist or medications prohibit the healing process. To put this in a meaningful context, this type of wound classification system helps clinicians and patients to identify common realistic outcomes (Table 2). By instituting and translating the WBP paradigm into practice, Woo et al. showed that healing can be improved in 4  weeks (t = 2·67, P = 0·01) in a cohort of 111 patient with leg and foot ulcers (10).

Table 2.

Wound classification according to healability

Wound prognosis Treat the cause Blood supply Coexisting medical condition/drugs
Healable Yes Adequate Does not prevent healing
Maintenance No* Adequate Possibly prevents healing
Non healable or palliative No Usually inadequate May prevent healing
*

Cause not treated because of lack of patient adherence or health system factors preventing access to resources. © Woo and Sibbald (24)

Patient‐centred concerns

A chronic wound may exert a devastating effect on patients by influencing many domains associated with quality of life including limited physical mobility, decreasing activities of daily living, as well as disruption to work, leisure activity (11) and social functioning (12). Patient‐centred concerns may also include treatment of pain (nociceptive and/or neuropathic) and related symptoms. Patients’ input into treatment preferences must be taken into account to enhance adherence. This model describes the extent to which a person is willing to follow through on agreed recommendations between the patient and the health care provider. The term adherence conveys a willingness on the patient’s part to actively participate in his or her care. Successful treatment of a chronic wound entails a spectrum of recommendations, often requiring significant lifestyle changes that are complex, intrusive and inconvenient. Oosterber and Blaschke (13) suggested several strategies to enhance adherence including patient education, regular follow‐up and support.

Local wound care

Tissue debridement

The wound bed is optimally prepared by aggressive and regular debridement of any firm eschar or soft slough (14). A firm eschar serves as a proinflammatory stimulus inhibiting healing, while the slough promotes bacteria proliferation (15). In persons with diabetes, callus is usually associated with increased local pressure and debridement should be accompanied by appropriate assessment of plantar pressure redistribution and patient adherence (15).

Infection

Early recognition and management of increased bacterial burden and infection is vital during the ongoing care of a patient with a chronic wound. Bacterial damage will cause wound deterioration, delaying wound healing and thereby increasing the risks of further morbidity and mortality (16). Critical colonisation and wound infection is common in certain patient populations such as those with diabetes partly related to their relative immunodeficiency (17) (high glucose levels, other impairment of granulocytic function or inflammatory cell chemotaxis defects). External contamination of the wound bed by microorganisms can occur from the environment, dressings, the patient’s secretions and their own hands along with the hands of health care provider (18). In view of the ubiquitous presence of microorganisms, the clinician must determine whether bacterial balance (contamination or colonisation) or bacterial damage (critical colonisation or infection) is present. The assessment of infection in a chronic wound is a bedside skill.

Cutting and Harding (19) proposed that evidence of red friable, exuberant granulation, increased discharge and new devitalised tissue along with other criteria are related to infection. In Gardner et al.’s study (20), additional symptoms and signs including pain, increase wound size, new areas of breakdown and odour were associated with wound infection. Patients with diabetes and neuropathy that have wounds probed to bone are more likely associated with osteomyelitis (21). However, in a systematic review of existing high quality Randomised Controlled Trail (RCT) evidence, Nelson et al. (22) could not find any conclusive evidence that individual signs and symptoms are reliable to identify wound infection.

Sibbald et al. (23) created a mnemonic NERDS© and STONES© (Figure 1) that represents the initials of the signs to categorise the two levels of bacterial damage or infection. This is a theoretical framework that requires further validation or modification. With the current proposal, two or three of these signs should be sought for the diagnosis in each level. If increased exudate and odour are present, additional signs are needed to determine if the damage is superficial, deep or both. This concept has been preliminarily validated in a study of 96 patients with leg and foot ulcers (24).

Figure 1.

Figure 1

Principles of NERDS and STONES.

Clinicians may consider different strategies to control bacterial burden dependent on involvement in the superficial or deep/surrounding compartment of the wound. The promotion of bacterial balance helps to maximise host resistance and prevent further contamination, colonisation and critical colonisation from setting the scene for infection (25).

Increased surface bacterial burden may be treated with antibacterial dressings or topical antimicrobial agents (26). Silver is a commonly used topical antimicrobial agent that has been shown to be effective against yeast, mould and a large number of Gram‐positive and Gram‐negative microorganisms, and several antibiotic resistant strains such as MRSA and VRE (27). Silver requires ionisation in an aqueous media to exert its antimicrobial effect (28).

Other antimicrobial agents that can be considered include iodine (29), chlorhexidine derivative (e.g. polyhexamethylene biguanide). Deeper infection would require with systemic antimicrobial therapies (30). The decision to prescribe antibiotics should be based primarily on clinical evaluation and supplemented by bacterial testing including culture results (30). Alternatively, non infective processes can produce an inflammatory response that can mimic infection (31).

Moisture balance

Appropriate moisture is required to facilitate the action of growth factors, cytokines and migration of cells including fibroblasts and keratinocytes (32). Previous systemic reviews failed to ascertain the superiority of one dressing class over another in various chronic wound types. There was no significant difference between modern advanced moisture controlling dressing and normal saline gauze 33, 34. However, saline gauze usually requires frequent dressing changes to maintain adequate moisture balance causing pain and trauma, damage to newly laid granulating tissue and this process is nursing time intensive and therefore costly (35).

Edge effect

Healing of chronic wounds maybe arrested for many reasons may be stalled for many reasons. The ‘edge effect’ refers to epithelium that is failing to migrate across a firm and level granulation base (36). The epidermal edge may have a steep cliff‐like appearance rather than the tapered edge of advancing purple‐pink epithelium that slopes into the mature granulation base.

Wound healing may be improved by local addition of deficient components including cells, growth factors and tissue matrix components (37). Another approach would include complementary therapies such as oxygen (topical versus systemic).

Could some of these non healing chronic wounds be triggered into a healing trajectory by addressing their oxygen demands?

Oxygen and wound healing

Increasing scientific evidence suggests stalled chronic wounds contain phenotypically altered cells with an increase in senescent cells that are less responsive to cellular signalling. There are also reports documenting decreased growth factors 38, 39 and other diminished cellular responses.

Oxygen and their reactive oxygen species are involved in all stages of wound healing, modulating cell migration, adhesion, proliferation, neovascularisation, remodelling and apoptosis 40, 41.

The key multifaceted roles of oxygen in wound healing include:

  • • 

    Energy metabolism – oxygen is the last electron acceptor for mitochondrial cytochrome oxidase leading to the production of high‐energy phosphates that are required for multiple cellular functions 42, 43.

  • • 

    Collagen synthesis – oxygen is involved in the hydroxylation of proline and lysine in procollagen that is crucial in collagen maturation 44, 45.

  • • 

    Neovascularisation – although relative hypoxia is required to engender neovascularisation, supplemental oxygen administration has been shown to sustain and accelerate vessel growth. Oxygen induces vascular endothelial growth factor mRNA levels in endothelial cells and macrophages in vivo 41, 46, 47. It may also facilitate wound contraction by triggering the differentiation of fibroblasts to active contracting myofibroblasts 48, 49, 50, 51.

  • • 

    Antimicrobial action – wound tissues are susceptible to increased bacterial burden under a relative hypoxic environment. Through the respiratory burst activity, oxygen is converted by leucocytic NADPH oxidase to a superoxide ion and other reactive oxygen species that are all lethal to bacteria 52, 53, 54, 55.

Oxygen is often relatively deficient in the local wound base because of disrupted vasculature and the high‐energy demand to support tissue regeneration (56). Diminished circulation and hypoxia increases lactate production secondary to anaerobic metabolism and is deleterious to wound healing (57). These levels will be even lower if the wound does not have enough blood supply to heal.

The function of macrophages, fibroblasts and endothelial cells is impaired if local perfusion and oxygenation are compromised in vitro (58). There is evidence to suggest that insufficient oxygen may lead to an increased bacterial load and poor collagen deposition. Conversely, previous studies (57) have shown that wound healing can be accelerated with hyperoxia. Heng et al. (58) stimulated a 90% healing rate in the topical oxygen group compared with only 22% in the control group (standard treatment). Some studies using hyperbaric oxygen therapy (HBOT) have produced positive effects on wound healing 59, 60, 61. Whether topical oxygen therapy has the same efficacy as HBOT remains to be established and topical therapy is not associated with increased circulating oxygen saturation in contrast to HBOT (62). Recently, Goretti et al. (63) synthesised a superoxidised solution with the electrolysis of water and sodium chloride to generate reactive species of chlorine and oxygen. They showed that healing time for patients with diabetes and foot ulcers was significantly reduced with the application of a superoxidised solution in comparison with their retrospective review of a cohort that were treated with povidone iodine 50% diluted in saline (P = 0·0036). Other authors argue that there is no proven advantage for topical oxygen application (64). While HBOT may improve wound healing, it should be pointed out that oxygen in high doses is toxic particularly to the brain and lungs. Other potential drawbacks of HBOT include damage to the ears and nasal sinuses, time and direct cost associated with daily travel to and from the treatment centre, and the psychological effect of confinement. Topical low dose of oxygen may be a feasible alternative.

Remaining challenges with WBP?

After several years of experience with the WBP model, it has become increasingly clear that microbial infections can lead to severe local hypoxia (65). Hypoxia does not favour healing, especially if anaerobic pathogens are involved. To minimise complications caused by infection, we should avoid hypoxic conditions (Table 3).

Table 3.

Why oxygen?

Large blood vessels Local wound
Supply oxygen to the tissue for repair and regeneration Needed for respiration
Provide tissue nutrients Neutrophil killing and other parts of host resistance versus bacteria
Optimise host resistance Collagen cross linking
One cigarette will decrease the delivered oxygen 30% or more for an hour Inhibit anaerobes
Chronic hypoxia perpetuates neutrophil infiltration

Oxygen balance and WBP?

Is oxygen balance – making sure that oxygen supply is balanced with oxygen demand – an important issue for every wound?

This concept is certainly not the same as attempting to treat every wound with HBOT, an extreme measure that saturates the body with oxygen, rather than achieving local balance.

Local oxygen balance should not be addressed by continuous exposure of the wound to air or pure oxygen, at the expense of all the other key aspects of WBP (66). Instead, local oxygen delivery may be integrated into our whole approach to good WBP, as part of the attempt to deal with all the needs of a wound (Table 4).

Table 4.

DIME with oxygen balance: an extension of the WBP

Clinical observations Molecular and cellular problems Clinical actions Effect of clinical actions Clinical outcome
Debridement Denatured matrix and cell debris impair healing Debridement (episodic or continuous) autolytic, sharp surgical, enzymatic, mechanical or biological Intact, functional, extracellular matrix proteins present in wound base Viable wound base
Infection, inflammation High bacteria, cause ↑ inflammatory cytokines, ↑ proteases, ↓ growth factor activity, ↓ healing environment Topical/systemic antimicrobials, anti‐inflammatories, protease inhibitors, growth factors Low bacteria, cause ↓ inflammatory cytokines, ↓ proteases, ↑ growth factor activity, ↑ healing environment Bacterial balance and reduced inflammation
Moisture imbalance Desiccation slows epithelial cell migration, excessive fluid causes maceration of wound base/margin Apply moisture‐balancing dressings Desiccation avoided, excessive fluid controlled Moisture balance
Edge of wound – non advancing or undermined Non migrating keratinocytes, Non responsive wound cells, abnormalities in extracellular matrix or abnormal protease activity Reassess cause, refer or consider corrective advanced therapies Responsive fibroblasts and keratinocytes present in wound Advancing edge of wound
Bioengineered skin
Skin grafts
Vascular surgery
Oxygen imbalance Hypoxia prevents optimal cellular function and allows anaerobic proliferation Oxygenating therapies (e.g. Oxyzyme) Cellular functions improved and infection controlled Improved wound healing and bacterial balance

One opportunity presented by this approach is that some non healing wounds could be helped by offering them advanced/adjunctive therapies which combine traditional WBP principles with oxygen balance (Figure 2). Would attention to this additional factor further increase rates of healing in relatively uncomplicated wounds? These important issues need to be addressed as we adapt and refine the WBP concept.

Figure 2.

Figure 2

A new wound bed preparation paradigm?

A new concept for wound healing – oxygen balance via an active oxygen‐concentrating wound dressing?

Oxyzyme™ is an advanced wound dressing technology consisting of a prehydrated, sheet hydrogel. Oxyzyme Sterile Wound Dressings are comfortable, easily removed hydrogel sheets that permit the absorption of fluids. The hydrogel format provides the critical elements of moisture balance and autolytic debridement, essential for optimising WBP (67). Through its unique enzyme‐driven actions, this gel dressing may also help to achieve the third local desired effect – bacterial balance.

When the dressing is removed from its airtight packaging and placed on the wound surface, the built‐in enzyme action is triggered to produce a low level and steady flux of hydrogen peroxide within the dressing over the course of about 12 h. Hydrogen peroxide is not able to escape beyond the dressing surface, as it is instantly decomposed to form dissolved oxygen and water. The overall effect is that hydrogen peroxide is used as an oxygen shuttle, transporting oxygen from the atmosphere to the wound environment. After peaking at around 6–8 hours, the oxygen delivery rate declines in a programmed manner until normoxia or slight hypoxia is achieved by 18–24 hhours. In addition to the metabolic benefits of the oxygen, it also helps inhibit anaerobic bacteria. This antimicrobial effect is further enhanced by the incorporation of a very low level of iodide (<0·04%) in the hydrogel. The hydrogen peroxide and iodide interact to produce molecular iodine and oxygen. Although the iodine is produced at low levels, it enhances the antimicrobial effectiveness of the dressing. This dressing may be considered for use across the whole chronic wound spectrum from the debridement stage through inflammation, remodelling and reepithelialisation 68, 69.

Perhaps oxygen balance may be achieved by this programmed, low‐level, pulsed oxygen concentrating effect. Wound care clinicians will watch with interest to determine its clinical performance through case studies and wider use, as the product becomes available.

Conclusions

The importance of local oxygen balance in the chronic wounds needs to be further substantiated with scientific evidence to decide whether ‘oxygen balance’ is a missing element from WBP. We present this to open the debate providing food for thought!

Conflicts of interest

RGS and DQ have acted as paid consultants to Archimed Ltd. and have received funding for research carried out in this work. KW declares no conflicts of interest.

References

  • 1. Margolis DJ, Allen‐Taylor L, Hoffstad O, Berlin JA. The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen 2004;12:163–8. [DOI] [PubMed] [Google Scholar]
  • 2. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005;26:306–19. [DOI] [PubMed] [Google Scholar]
  • 3. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW. Tissue inhibitor of metalloprotieinases‐1 is decreased and activated gelatinases are increase in chronic wounds. J Invest Dermatol 1995;104:236–40. [DOI] [PubMed] [Google Scholar]
  • 4. Hollinworth H. Sharing the burden: the complex practice of wound care in the community. Br J Community Nurs 2004;9:5–10. [DOI] [PubMed] [Google Scholar]
  • 5. Winter GD. Formation of scab and the rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293–4. [DOI] [PubMed] [Google Scholar]
  • 6. Queen D, Orsted HL, Sanada H, Sussman GA. Dressing history. Int Wound J 2004;1:59–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Sibbald RG, Orsted HL, Schultz GS, Coutts P, Keast DH. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 2003;49:24–51. [PubMed] [Google Scholar]
  • 8. Sibbald RG, Williamson D, Orsted HL, Campbell K, Keast D, Krasner D, Sibbald D. Preparing the wound bed: debridement, bacterial balance and moisture balance. Ostomy Wound Manage 2000;46:14–35. [PubMed] [Google Scholar]
  • 9. Falanga V, Saap LJ, Ozonoff A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther 2006;19:383–90. [DOI] [PubMed] [Google Scholar]
  • 10. Woo K, Lo C, Queen D, Rothman A, Woodbury G, Sibbald M, Noseworthy P, Anderson C, Purbhoo D, Sibbald RG. An audit of leg and foot ulcer care in Ontario CCAC. Wound Care Canada 2007;5 (Suppl. 1):s17–27. [Google Scholar]
  • 11. Valensi P, Schwarz EH, Hall M, Felton AM, Maldonato A, Mathieu C. Pre‐diabetes essential action: a European perspective. Diabetes Metab 2005;31:606–20. [DOI] [PubMed] [Google Scholar]
  • 12. Price PE, Harding KG. Cardiff Wound Impact Schedule: the development of a condition‐specific questionnaire to assess health‐related quality of life in patients with chronic wounds of the lower limb. Int Wound J 2004;1:10–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Oosterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med 2005;353:487–97. [DOI] [PubMed] [Google Scholar]
  • 14. Fowler E, Van Rijswijk L. Using wound debridement to help achieve the goals of care. Ostomy Wound Manage 1995;41:23S–35S. [PubMed] [Google Scholar]
  • 15. Inlow S, Orsted H, Sibbald RG. Best practices for the prevention, diagnosis, and treatment of diabetic foot ulcers. Ostomy Wound Manage 2000;46:55–68. [PubMed] [Google Scholar]
  • 16. Goldenheim PD. An appraisal of povidone‐iodine and wound healing. Postgrad Med J 1993;69 (Suppl. 3):S97–105. [PubMed] [Google Scholar]
  • 17. Xu L, McLennan SV, Lo L, Natfaji A, Bolton T, Liu Y, Twigg SM, Yue DK. Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 2007;30:378–80. [DOI] [PubMed] [Google Scholar]
  • 18. Fendler EJ, Ali Y, Hammond BS, Lyons MK, Kelley MB, Vowell NA. The impact of alcohol hand sanitizer use on infection rates in an extended care facility. Am J Infect Control 2002;30:226–33. [DOI] [PubMed] [Google Scholar]
  • 19. Cutting KF, Harding KG. Criteria for identifying wound infection. J Wound Care 1994;3:198–201. [DOI] [PubMed] [Google Scholar]
  • 20. Gardner SE, Frantz RA, Park H, Scherubel M. The inter‐rater reliability of the clinical signs and symptoms checklist in diabetic foot ulcers. Ostomy Wound Manage 2007;53:46–51. [PubMed] [Google Scholar]
  • 21. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721–3. [PubMed] [Google Scholar]
  • 22. Nelson EA, O’Meara S, Craig D, Iglesias C, Golder S, Dalton J, Claxton K, Bell‐Syer SEM, Jude E, Dowson C, Gadsby R, O’Hare P, Powell J. A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technol Assess 2006;10:iii–iv, ix–x, 1–221. [DOI] [PubMed] [Google Scholar]
  • 23. Sibbald RG, Woo K, Ayello EA. Increased bacterial burden and infection: the story of NERDS and STONES. Adv Skin Wound Care 2006;19:447–61. [DOI] [PubMed] [Google Scholar]
  • 24. Woo K, Sibbald RG. Infection and chronic wound care. Presentation at Symposium Advanced Wound Care, Tampa, FL, 2007. [Google Scholar]
  • 25. Ovington LG. Dressings and adjunctive therapies: AHCPR guidelines revisited. Ostomy Wound Manage 1999;45 (Suppl 1A):94S–106S. [PubMed] [Google Scholar]
  • 26. Cutting K, White RJ, Edmonds M. The safety and efficacy of dressings with silver – addressing clinical concerns. Int Wound J 2007;4:177–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Leaper DJ. Silver dressings: their role in wound management. Int Wound J 2006;3:282–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Percival SL, Bowler PG, Dolman J. Antimicrobial activity of silver‐containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007;4:186–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Cooper RA. Iodine revisited. Int Wound J 2007;4:124–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Landis S, Ryan S, Woo K, Sibbald RG. Infections in chronic wounds. In: Chronic wound care: a clinical source book for healthcare professionals, 4th edn. Krasner D, Roedeheaver G & Sibbald RG (eds) HMP Communications, PA, USA, 2007:299–321. [Google Scholar]
  • 31. Sibbald RG, Orsted HL, Coutts PM, Keast DH. Best practice recommendations for preparing the wound bed: update 2006. Wound Care Canada 2006;4:R6–18. [DOI] [PubMed] [Google Scholar]
  • 32. Okan D, Woo K, Ayello EA, Sibbald RG. The role of moisture balance in wound healing. Adv Skin Wound Care 2007;20:39–53. [DOI] [PubMed] [Google Scholar]
  • 33. Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy Wound Manage 2001;47:38–43. [PubMed] [Google Scholar]
  • 34. Coutts P, Sibbald RG. The effect of silver containing Hydrofiber® dressing on superficial wound bed and bacterial balance of chronic wounds. Int Wound J 2005;2:348–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Harding K, Cutting K, Price P. The cost‐effectiveness of wound management protocols of care. Br J Nurs 2000;9 (Suppl. 19):S6, S8, S10 passim. [DOI] [PubMed] [Google Scholar]
  • 36. Schultz GS, Barillo DJ, Mozingo DW, Chin GA. Wound bed preparation and a brief history of TIME. Int Wound J 2004;1:19–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Woo K, Ayello EA, Sibbald RG. The edge effect: current therapeutic options to advance the wound edge. Adv Skin Wound Care 2007;20:99–117. [DOI] [PubMed] [Google Scholar]
  • 38. Davidson JD, Mustoe TA. Oxygen in wound healing: more than a nutrient. Wound Repair Regen 2001;9:175–7. [DOI] [PubMed] [Google Scholar]
  • 39. Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S. Oxygen, oxidants and antioxidants in wound healing. Ann NY Acad Sci 2002;957:239–49. [DOI] [PubMed] [Google Scholar]
  • 40. Black J. Tissue oxygen perfusion and pressure ulcer healing. Plast Surg Nurs 2000;20:10–4. [DOI] [PubMed] [Google Scholar]
  • 41. Chaudhuri V, Potts BR, Karasek MA. Mechanisms of microvascular wound repair I. Role of mitosis, oxygen tension and I‐kappa B. In Vitro Cell Dev Biol 2006;42:308–13. [DOI] [PubMed] [Google Scholar]
  • 42. Patel V, Chivukula IV, Roy S, Khanna S, He G, Ojha N, Mehrota A, Dias LM, Hunt TK, Sen CK. Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. [Erratum appears in Antioxid Redox Signal. 2005; 7(11): 1783.]. Antioxid Redox Signal 2005;7:1377–87. [DOI] [PubMed] [Google Scholar]
  • 43. Kairuz E, Upton Z, Dawson RA, Malda J. Hyperbaric oxygen stimulates epidermal reconstruction in human skin equivalents. Wound Repair Regen 2007;15:266–74. [DOI] [PubMed] [Google Scholar]
  • 44. Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH III, Jensen JA, Jonsson K, Paty PB, Rabkin JM, Upton RA, Von Smitten K, Whitney JD. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch J Surg 1997;132:997–1004. [DOI] [PubMed] [Google Scholar]
  • 45. Shiekh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg 2000;135:1293–7. [DOI] [PubMed] [Google Scholar]
  • 46. Cho M, Hunt TK, Hussain MZ. Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am J Physiol Heart Circ Physiol 2001;280:2357–63. [DOI] [PubMed] [Google Scholar]
  • 47. Dominguez‐Rosales JA, Mavi G, Levenson SM, Rojkind M. H2O2 is an important mediator of physiological and pathological healing responses. Arch Med Res 2000;31:15–20. [DOI] [PubMed] [Google Scholar]
  • 48. Allen DB, Maguire JJ, Mahdavian M, Wicke C, Marcocci L, Scheuenstuhl H, Chang M, Le AX, Hopf HW, Hunt TK. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997;132:997–1004. [DOI] [PubMed] [Google Scholar]
  • 49. Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 1986;121:191–5. [DOI] [PubMed] [Google Scholar]
  • 50. Akca O, Doufas G, Morioka N, Iscoe S, Fisher J, Sessler DI. Hypercapnia improves tissue oxygenation. Anesthesiology 2002;97:801–6. [DOI] [PubMed] [Google Scholar]
  • 51. Gordillo GM, Sen CK. Revisiting the essential role of oxygen in wound healing. Am J Surg 2003;186:259–63. [DOI] [PubMed] [Google Scholar]
  • 52. Hunt TK, Ellison EC, Sen CK. Oxygen: at the foundation of wound healing – introduction. World J Surg 2004;28:291–3. [DOI] [PubMed] [Google Scholar]
  • 53. Knighton DR, Silver IA, Hunt TK. Regulation of wound‐healing angiogenesis‐effect of oxygen gradients and inspired oxygen concentration. Surgery 1981;90:262–70. [PubMed] [Google Scholar]
  • 54. Pai MP, Hunt TK. Effect of varying oxygen tensions on healing of open wounds. Surg Gynecol Obstet 1972;135:756–8. [PubMed] [Google Scholar]
  • 55. Kivissaari J, Niinikosi J. Effects of hyperbaric oxygenation and prolonged hypoxia on the healing of open wounds. Acta Chir Scand 1975;141:14. [PubMed] [Google Scholar]
  • 56. Fries RB, Wallace WA, Roy S, Kuppusamy P, Bergdall V, Gordillo GM, Melvin WS, Sen CK. Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res 2005;579:172–81. [DOI] [PubMed] [Google Scholar]
  • 57. Black J. Tissue oxygen perfusion and pressure ulcer healing. Plast Surg Nurs 2000;20:10–4. [DOI] [PubMed] [Google Scholar]
  • 58. Heng MC, Harker J, Csathy G, Marshall C, Brazier J, Sumampong S, Paterno Gomez E. Angiogenesis in necrotic ulcers treated with hyperbaric oxygen. Ostomy Wound Manage 2000;46:18–28, 30–2. [PubMed] [Google Scholar]
  • 59. Rosenthal AM, Schurman A. Hyperbaric treatment of pressure sores. Arch Phys Med Rehabil 52:413–5. [PubMed] [Google Scholar]
  • 60. Hammarlund C, Sundberg T. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double‐blind study. Plast Reconstr Surg 1994;93:829–33. [PubMed] [Google Scholar]
  • 61. Roeckl‐Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Brit J Surg 2005;92:24–32. [DOI] [PubMed] [Google Scholar]
  • 62. Said HK, Hijawi J, Roy N, Mogford J, Mustoe T. Transdermal sustained‐delivery oxygen improves epithelial healing in a rabbit ear wound model. Arch Surg 2005;140:998–1004. [DOI] [PubMed] [Google Scholar]
  • 63. Goretti C, Mazzurco S, Ambrosini Nobili L, Macchiarini S, Tedeschi A, Palumbo F, Scatena A, Rizzo L, Piaggesi A. Clinical outcomes of wide postsurgical lesions in the infected diabetic foot managed with 2 different local treatment regimes compared using a quasi‐experimental study design: a preliminary communication. Int J Low Extrem Wounds 2007;6:22–7. [DOI] [PubMed] [Google Scholar]
  • 64. Benditt J. Adverse effects of low‐flow oxygen therapy. Respir Care 2000;45:54–61; discussion 61–4. [PubMed] [Google Scholar]
  • 65. Ueno C, Hunt TK, Hopf HW. Using physiology to improve surgical wound outcomes Plast Reconstr Surg 2006;117 (Suppl. 7):59S–71S. [DOI] [PubMed] [Google Scholar]
  • 66. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al‐Attar A, Couch K. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound‐healing adjuvants. Plast Reconstr Surg 2006;117 (Suppl. 7):72S–109S. [DOI] [PubMed] [Google Scholar]
  • 67. Dowsett C, Claxton K. Reviewing the evidence for wound bed preparation. J Wound Care 2006;15:439–42. [DOI] [PubMed] [Google Scholar]
  • 68. Queen D, Coutts P, Fierheller M, Sibbald RG. The use of a novel oxygenating hydrogel dressing in the treatment of different chronic wounds. Adv Skin Wound Care 2007;20:200–6. [DOI] [PubMed] [Google Scholar]
  • 69. Ivins N, Simmonds W, Turner A, Harding K. The use of an oxygenating hydrogel dressing in VLU. Wounds UK 2007;3. [Google Scholar]

Articles from International Wound Journal are provided here courtesy of Wiley

RESOURCES